These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38928345)
41. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX J Pathol; 2011 Sep; 225(1):54-62. PubMed ID: 21598254 [TBL] [Abstract][Full Text] [Related]
42. Epigenomic approach in understanding Alzheimer's disease and type 2 diabetes mellitus. Shaik MM; Gan SH; Kamal MA CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):283-9. PubMed ID: 24074446 [TBL] [Abstract][Full Text] [Related]
43. Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer's disease: review, recommendation, implementation and application. Wang M; Song WM; Ming C; Wang Q; Zhou X; Xu P; Krek A; Yoon Y; Ho L; Orr ME; Yuan GC; Zhang B Mol Neurodegener; 2022 Mar; 17(1):17. PubMed ID: 35236372 [TBL] [Abstract][Full Text] [Related]
44. Insulin resistance in Alzheimer's disease: The genetics and metabolomics links. Amin AM; Mostafa H; Khojah HMJ Clin Chim Acta; 2023 Jan; 539():215-236. PubMed ID: 36566957 [TBL] [Abstract][Full Text] [Related]
45. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer's disease. McKenzie AT; Moyon S; Wang M; Katsyv I; Song WM; Zhou X; Dammer EB; Duong DM; Aaker J; Zhao Y; Beckmann N; Wang P; Zhu J; Lah JJ; Seyfried NT; Levey AI; Katsel P; Haroutunian V; Schadt EE; Popko B; Casaccia P; Zhang B Mol Neurodegener; 2017 Nov; 12(1):82. PubMed ID: 29110684 [TBL] [Abstract][Full Text] [Related]
46. The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer's disease, type 2 diabetes, and type 2 diabetes-related Alzheimer's disease. He L; Sun Y Metab Brain Dis; 2021 Oct; 36(7):1469-1479. PubMed ID: 34129198 [TBL] [Abstract][Full Text] [Related]
47. Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer's Disease. Mittal K; Mani RJ; Katare DP Sci Rep; 2016 May; 6():25589. PubMed ID: 27151376 [TBL] [Abstract][Full Text] [Related]
48. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects. Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474 [TBL] [Abstract][Full Text] [Related]
49. Crucial players in Alzheimer's disease and diabetes mellitus: Friends or foes? Kubis-Kubiak AM; Rorbach-Dolata A; Piwowar A Mech Ageing Dev; 2019 Jul; 181():7-21. PubMed ID: 31085195 [TBL] [Abstract][Full Text] [Related]
50. Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease. Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX J Neurochem; 2009 Oct; 111(1):242-9. PubMed ID: 19659459 [TBL] [Abstract][Full Text] [Related]
51. Genomic linkage between Alzheimer's disease and type 2 diabetes. Nedjadi T; Haque A; Alam Q; Gan SH; Chaudhary AG; Abuzenadah AM; Damanhouri GA; Kamal MA CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):203-12. PubMed ID: 24059319 [TBL] [Abstract][Full Text] [Related]
52. The Role of Steroidomics in the Diagnosis of Alzheimer's Disease and Type 2 Diabetes Mellitus. Vaňková M; Velíková M; Vejražková D; Včelák J; Lukášová P; Rusina R; Vaňková H; Jarolímová E; Kancheva R; Bulant J; Horáčková L; Bendlová B; Hill M Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239922 [TBL] [Abstract][Full Text] [Related]
53. Type 2 Diabetes Mellitus and Alzheimer's Disease: Overlapping Biologic Mechanisms and Environmental Risk Factors. Paul KC; Jerrett M; Ritz B Curr Environ Health Rep; 2018 Mar; 5(1):44-58. PubMed ID: 29464502 [TBL] [Abstract][Full Text] [Related]
54. A molecular bridge: connecting type 2 diabetes and Alzheimer's disease. Ahmed F; Ansari JA; Ansari ZE; Alam Q; Gan SH; Kamal MA; Ahmad E CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):312-21. PubMed ID: 24059325 [TBL] [Abstract][Full Text] [Related]
55. Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation. Kamal MA; Priyamvada S; Anbazhagan AN; Jabir NR; Tabrez S; Greig NH CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):338-46. PubMed ID: 24074448 [TBL] [Abstract][Full Text] [Related]
56. Exploring Shared Biomarkers of Myocardial Infarction and Alzheimer's Disease via Single-Cell/Nucleus Sequencing and Bioinformatics Analysis. Xue W; He W; Yan M; Zhao H; Pi J J Alzheimers Dis; 2023; 96(2):705-723. PubMed ID: 37840493 [TBL] [Abstract][Full Text] [Related]
57. Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus. Klimova B; Kuca K; Maresova P Curr Alzheimer Res; 2018; 15(14):1277-1282. PubMed ID: 30251605 [TBL] [Abstract][Full Text] [Related]
58. Improvement in Zebrafish with Diabetes and Alzheimer's Disease Treated with Pasteurized Akkermansia muciniphila. Qu L; Liu F; Fang Y; Wang L; Chen H; Yang Q; Dong H; Jin L; Wu W; Sun D Microbiol Spectr; 2023 Jun; 11(3):e0084923. PubMed ID: 37191572 [TBL] [Abstract][Full Text] [Related]
59. Optimizing clinical phenotyping to better delineate the complex relationship between type 2 diabetes and Alzheimer's disease. Hanson AJ; Rubinow KB Clin Transl Sci; 2021 Sep; 14(5):1681-1688. PubMed ID: 33742772 [TBL] [Abstract][Full Text] [Related]
60. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease. Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]